Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Vitex Agnus-castus BNO 1095 (20 mg) in Women With Primary Dysmenorrhea

NCT06211049 is registered in ClinicalTrials.gov with Bionorica SE as lead sponsor.

NCT NCT06211049
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06211049 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Vitex Agnus-castus BNO 1095 (20 mg) in Women With Primary Dysmenorrhea
Lead sponsor
Bionorica SE
Phase
Phase 3
Overall status
Completed
Start date
December 12, 2023
Completion date
July 23, 2025
Enrollment
335 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

primary dysmenorrhea